Bluebird bio Inc [NASDAQ: BLUE] traded at a high on Tuesday, posting a 7.84 gain after which it closed the day’ session at $1.10. The company report on January 8, 2024 at 8:00 AM that bluebird bio Provides Update on Commercial Launch Progress, Program Milestones,
Bluebird bio Inc [NASDAQ: BLUE] gained 5.83% or 0.06 points to close at $1.09 with a heavy trading volume of 6125430 shares. The company report on January 8, 2024 at 8:00 AM that bluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024
Bluebird bio Inc [NASDAQ: BLUE] loss -4.27% or -0.04 points to close at $0.96 with a heavy trading volume of 10225190 shares. The company report on January 8, 2024 at 8:00 AM that bluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024
Bluebird bio Inc [NASDAQ: BLUE] gained 6.60% or 0.07 points to close at $1.13 with a heavy trading volume of 6729528 shares. The company report on January 8, 2024 at 8:00 AM that bluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024
© 2024, Powered by Smart TechOne
